ADIM
SWBI icon

Alpha DNA Investment Management’s Smith & Wesson SWBI Stock Holding History

Alpha DNA Investment Management’s Portfolio SWBI Stock Details SWBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11
Closed – – 580
2021
Q1 		$0 Sell
11
-33,137
-100% -$603K ﹤0.01% 773
2020
Q4 		$588K Buy
+33,148
New +$548K 0.63% 75

Other funds holding SWBI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpha DNA Investment Management's SWBI Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Smith & Wesson (SWBI) in Q2 2021, closing a stake of 11 shares.

Alpha DNA Investment Management first reported a position in SWBI in Q4 2020 and held it in 2 quarters. The position peaked at $588K in Q4 2020. 251 funds tracked by Wall St. Rank hold SWBI as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Smith & Wesson position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 11 Smith & Wesson shares in Q2 2021.
  • Alpha DNA Investment Management first reported a position in Smith & Wesson in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Smith & Wesson position peaked at $588K in Q4 2020.
  • 251 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.